(1 - 12 von 13
)
EMA Grants Orphan Drug Designation to Debiopharm International SA's...
www.informazione.it
Orphan Drug Designation by the EMA provides regulatory and financial incentives to develop therapies for life-threatening or chronically debilitating…
FDA Grants Orphan Drug Designation to Debiopharm International SA's...
www.wallstreet-online.de
is an important regulatory milestone", stated Peggy Lipp, Director, Regulatory Affairs, Business Intelligence & Market Access, Debiopharm
News for Medical Independent Sales Representatives and Medical...
salesandmarketingnetwork.com
Healthcare Sales & Marketing Network: FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio in the Treatment of Ovarian...
FDA grants fast track designation to Debio for FGFR
www.healio.com
— Peggy Lipp, director of regulatory affairs, market intelligence and market access at Debiopharm International, said in a company-issued ... › online
sortiert nach Relevanz / Datum